Micro-Tech (Nanjing) shareholder reduces stake; hemostatic clip patent upheld

Micro-Tech (Nanjing) Co., Ltd. announced that its shareholder, Shenzhen Zhongke Zhaoshang Venture Capital Co., Ltd., reduced its holdings by 62,000 shares through centralized bidding. Shares were sold at prices between CNY 97.50 and CNY 100.90 per share, totaling CNY 6,224,908.54. This represents 0.03% of the company's total share capital, leaving 41,690,818 shares or 22.1940% of the total shares. The original plan allowed for a reduction of up to 2%, with 3,694,948 shares remaining uncompleted from the reduction plan.

In a separate development, the China National Intellectual Property Administration upheld the validity of Micro-Tech (Nanjing)'s "hemostatic clip" invention patent (Patent No. 201410222753.7). This ruling was made against an invalidation request by Beijing Zhongke Shengkang Technology Co., Ltd. The decision maintains the effectiveness of claims 1-8 of the patent, affirming the company's intellectual property rights and not negatively impacting its current or future operations. This patent is also central to ongoing infringement litigation where Micro-Tech (Nanjing) previously won a first-instance ruling.

The company will hold a third-quarter 2025 performance briefing on December 16, 2025, from 10:00 AM to 11:00 AM, via the Shanghai Stock Exchange Roadshow Center to discuss its financial results and address investor inquiries.